Sign In
Step 1
Draft
Step 2
Unite with Fellow Investors
Step 3
Choose the Best Attorney
Step 4
Provide Documents
Step 5
Follow Case Progress
Step 6
Get Payout
GERN.US
id: 267

Geron Corporation (GERN) $24M Shareholder Settlement

The settlement funds have been distributed to claimants.
$24,000,000
Cash Settlement
N.D. California
Court
3:20-cv-00547
Case number
03/19/2018
Class period Start
09/26/2018
Class period End
07/14/2023
Claim deadline
Geron Corporation (GERN) settles $24 million with investors in a lawsuit over misleading statements related to IMbark study data.

The Company and its Leaders, along with Geron’s development partner, Janssen Biotech Inc. (“Janssen”), a division of Johnson & Johnson, were conducting a Phase 2 clinical trial called IMbark on Geron’s only drug candidate, imetelstat.

  • It is alleged that the Company and its Leaders made materially false and misleading statements to investors, and failed to disclose material facts Defendants had a duty to disclose to make their representations not misleading, concerning certain study data results from the IMbark study and certain risk factors.
  • The Complaint alleges that Defendants should have disclosed the allegedly bad news about the IMbark study data when they disclosed allegedly good news about the study.
  • Allegedly, when the truth was disclosed at the end of the Class Period, Geron’s stock declined by over 71%.
Case Status
Disbursed
Alleged Offence
Other
Suspected Party
Other
Security Type
Stocks
Trade Direction
Long
Payout per Share
0.17
Plaintiffs
Johnson Fistel LLP, Julia Junge, Richard Junge
Attorneys
Kaplan Fox & Kilsheimer LLP
Judge
Hon. William Alsup
Administrator
EPIQ
Court hearing date
08/24/2023
Exclusion deadline
07/14/2023
Objection deadline
03/09/2023
Hearing deadline
03/09/2023
Settlement conditions
$14000000 by cash, and $7000000 by Securities
Trades matching type
FIFO
Disbursement date
07/11/2024

How Do Class Action Settlements Work and How Can Investors Get Paid?

How Can Financial Institutions Recover Settlement Funds with 11th.com?

Why Do Investors Trust 11th.com?

Trusted by industry leaders

Endorsed by top professionals who trust our innovative solutions to drive impactful results.